BSE Prices delayed by 5 minutes ! Prices as on   Jul 10, 2026   ABB India 6833.55 [ 0.20% ]ACC 1384.75 [ 1.73% ]Ambuja Cements 436.25 [ 1.77% ]Asian Paints 2677.8 [ 0.20% ]Axis Bank 1323.75 [ 1.91% ]Bajaj Auto 10163.4 [ 0.10% ]Bank of Baroda 251 [ 2.64% ]Bharti Airtel 1921.1 [ -0.49% ]Bharat Heavy 395.3 [ 3.60% ]Bharat Petroleum 309.7 [ 0.47% ]Britannia Industries 5353.7 [ -0.16% ]Cipla 1438.75 [ -0.20% ]Coal India 429.45 [ -0.17% ]Colgate Palm 2051.9 [ -0.49% ]Dabur India 443.45 [ 0.05% ]DLF 685.7 [ 3.90% ]Dr. Reddy's Lab. 1245.5 [ -1.91% ]GAIL (India) 173.6 [ 1.88% ]Grasim Industries 3212.05 [ 0.64% ]HCL Technologies 1162.65 [ 1.14% ]HDFC Bank 824.25 [ 0.80% ]Hero MotoCorp 4948.35 [ 1.02% ]Hindustan Unilever 2149.3 [ 0.24% ]Hindalco Industries 967.1 [ 0.36% ]ICICI Bank 1401.45 [ 1.44% ]Indian Hotels Co. 752.1 [ 2.84% ]IndusInd Bank 1016.25 [ 0.12% ]Infosys 1068.05 [ 1.71% ]ITC 281.9 [ -0.02% ]Jindal Steel 1051.6 [ 2.05% ]Kotak Mahindra Bank 377.8 [ 0.20% ]L&T 3946.55 [ 1.52% ]Lupin 2496.05 [ -0.27% ]Mahi. & Mahi 3129.15 [ 1.42% ]Maruti Suzuki India 13859.25 [ 0.95% ]MTNL 29.29 [ 1.31% ]Nestle India 1456.65 [ -0.45% ]NIIT 100.85 [ 1.10% ]NMDC 84.88 [ 0.59% ]NTPC 344.5 [ 0.29% ]ONGC 245 [ 0.53% ]Punj. NationlBak 105.4 [ 1.88% ]Power Grid Corpn. 283.2 [ 0.73% ]Reliance Industries 1308.85 [ 2.28% ]SBI 1036.15 [ 1.42% ]Vedanta 272.6 [ 0.44% ]Shipping Corpn. 284.9 [ 2.69% ]Sun Pharmaceutical 1935.25 [ -0.19% ]Tata Chemicals 720 [ 0.74% ]Tata Consumer 1111.9 [ 0.47% ]Tata Motors Passenge 338.1 [ 1.93% ]Tata Steel 191.15 [ 1.78% ]Tata Power Co. 381.25 [ 1.56% ]Tata Consult. Serv. 2069.05 [ 1.04% ]Tech Mahindra 1455.45 [ 2.19% ]UltraTech Cement 11713.55 [ 1.72% ]United Spirits 1386.4 [ 0.46% ]Wipro 175.35 [ 1.51% ]Zee Entertainment 97.1 [ -2.71% ]
BSE

MARKETS

News Details

( As on 09/07/2026 12:35)

Dr. Reddy's delays commercial launch of anti-diabetic semaglutide over API Quality issue

Dr. Reddy's Laboratories has announced a temporary delay in the commercial supply of its anti-diabetic drug semaglutide after certain batches failed to meet quality specifications due to an issue with the active pharmaceutical ingredient (API).

The company said the affected batches were found to be out of specification because of the API-related issue. It clarified that there is no impact on patient safety and that it is investigating the root cause while taking corrective measures to ensure product quality before commercial distribution resumes.

Dr. Reddy's did not specify the duration of the delay but stated that commercial supplies will be postponed until the quality issue is resolved.